Showing 1 - 7 results of 7 for search 'JESÚS RUIZ-ARAGÓN', query time: 0.03s Refine Results
  1. 1
    An Economic Comparison in the Elderly of Adjuvanted Quadrivalent Influenza Vaccine with Recombinant Quadrivalent Influenza Vaccine in Spain

    An Economic Comparison in the Elderly of Adjuvanted Quadrivalent Influenza Vaccine with Recombinant Quadrivalent Influenza Vaccine in Spain by Jesús Ruiz-Aragón, Sergio Márquez-Peláez

    Published 2023-02-01
    Get full text
    Article
  2. 2
    Reply to letter from Alvarez et al.

    Reply to letter from Alvarez et al. by Jesús Ruiz-Aragón, Ray Gani, Sergio Márquez, Piedad Alvarez

    Published 2021-03-01
    Get full text
    Article
  3. 3
    Estimated cost-effectiveness and burden of disease associated with quadrivalent cell-based and egg-based influenza vaccines in Spain

    Estimated cost-effectiveness and burden of disease associated with quadrivalent cell-based and egg-based influenza vaccines in Spain by Jesús Ruiz-Aragón, Ray Gani, Sergio Márquez, Piedad Alvarez

    Published 2020-09-01
    Get full text
    Article
  4. 4
    Cost-Effectiveness and Burden of Disease for Adjuvanted Quadrivalent Influenza Vaccines Compared to High-Dose Quadrivalent Influenza Vaccines in Elderly Patients in Spain

    Cost-Effectiveness and Burden of Disease for Adjuvanted Quadrivalent Influenza Vaccines Compared to High-Dose Quadrivalent Influenza Vaccines in Elderly Patients in Spain by Jesús Ruiz-Aragón, Sergio Márquez-Peláez, Ray Gani, Piedad Alvarez, Richard Guerrero-Luduena

    Published 2022-01-01
    Get full text
    Article
  5. 5
    Evaluación del sistema de navegación magnética intracardiaca Niobe®, revisión sistemática de la literatura científica

    Evaluación del sistema de navegación magnética intracardiaca Niobe®, revisión sistemática de la literatura científica by JESÚS RUIZ-ARAGÓN, JUAN MÁXIMO MOLINA-LINDE, SERGIO MÁRQUEZ-PELÁEZ, ROCÍO RODRÍGUEZ-LÓPEZ

    Published 2011-01-01
    Get full text
    Article
  6. 6
    An Economic Evaluation of the Adjuvanted Quadrivalent Influenza Vaccine Compared with Standard-Dose Quadrivalent Influenza Vaccine in the Spanish Older Adult Population

    An Economic Evaluation of the Adjuvanted Quadrivalent Influenza Vaccine Compared with Standard-Dose Quadrivalent Influenza Vaccine in the Spanish Older Adult Population by Anna Fochesato, Sara Sottile, Andrea Pugliese, Sergio Márquez-Peláez, Hector Toro-Diaz, Ray Gani, Piedad Alvarez, Jesús Ruiz-Aragón

    Published 2022-08-01
    Get full text
    Article
  7. 7
    Real-World Evidence in Cost-Effectiveness Analysis of Enhanced Influenza Vaccines in Adults ≥ 65 Years of Age: Literature Review and Expert Opinion

    Real-World Evidence in Cost-Effectiveness Analysis of Enhanced Influenza Vaccines in Adults ≥ 65 Years of Age: Literature Review and Expert Opinion by Maarten Postma, David Fisman, Norberto Giglio, Sergio Márquez-Peláez, Van Hung Nguyen, Andrea Pugliese, Jesús Ruiz-Aragón, Analia Urueña, Joaquin Mould-Quevedo

    Published 2023-06-01
    Get full text
    Article

Search Tools: